George Golumbeski's Net Worth

$1.27 Million

Estimate Recalculated Nov 11, 2024 08:52AM EST

Who is George Golumbeski?

George Golumbeski has an estimated net worth of $1.27 Million. This is based on reported shares across multiple companies, which include ENANTA PHARMACEUTICALS INC, Shattuck Labs, Inc., Sage Therapeutics, Inc., Corbus Pharmaceuticals Holdings, Inc., ACCELERON PHARMA INC, and Mural Oncology plc.

SEC CIK

George Golumbeski's CIK is 0001586660

Past Insider Trading and Trends

2019 was George Golumbeski's most active year for acquiring shares with 7 total transactions. George Golumbeski's most active month to acquire stocks was the month of January. 2019 was George Golumbeski's most active year for disposing of shares, totalling 7 transactions. George Golumbeski's most active month to dispose stocks was the month of January. 2019 saw George Golumbeski paying a total of $710,870.80 for 57,780 shares, this is the most they've acquired in one year. In 2019 George Golumbeski cashed out on 45,560 shares for a total of $2,177,750.55, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

ENANTA PHARMACEUTICALS INC (ENTA) Snapshot price: $11.54

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Feb 26
Form 4
—
0
$70.13
-$622,156.26
0
Scheduled
Mar 4
Form 4
—
0
—
—
0
Feb 28
Form 4
—
0
$58.78
-$844,723.49
0
Scheduled
Feb 11 - Feb 12
Form 4
—
0
—
—
0
Feb 28
Form 4
—
0
—
—
0
Feb 16
Form 4
—
0
—
—
0
Feb 11
Form 4
—
0
—
—
0
Feb 19
Form 4
—
0
—
—
0
Feb 7
Form 3
—
0
—
—
0
Form 3
—
0
—
—
0
No matching records found

Shattuck Labs, Inc. (STTK) Snapshot price: $3.5

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 21
Form 4
—
0
—
—
0
May 26
Form 4
—
0
—
—
0
Jun 8
Form 4
+107.79%
28.33K
$3.63
$102,837.90
54.61K
Apr 26
Form 4
∞
26.28K
$3.69
$96,979.59
26.28K
Apr 21 - Apr 22
Form 4
—
0
—
—
0
Jun 19
Form 4
—
0
—
—
0
Dec 22
Form 3
—
0
—
—
0
No matching records found

Sage Therapeutics, Inc. (SAGE) Snapshot price: $7.5

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 10
Form 4
—
0
—
—
0
Jan 3
Form 4
—
0
—
—
0
Jun 15
Form 4
—
0
—
—
0
Jan 4
Form 4
—
0
—
—
0
Jun 16
Form 4
∞
8K
$31.45
$251,563.20
8K
May 5
Form 4
—
0
—
—
0
Jan 4
Form 4
—
0
—
—
0
Jun 10
Form 4
—
0
—
—
0
Jan 5
Form 4
—
0
—
—
0
Jun 9
Form 4
—
0
—
—
0
Jan 3
Form 4
—
0
—
—
0
Jun 5
Form 4
—
0
—
—
0
Jan 22
Form 3
—
0
—
—
0
No matching records found

Corbus Pharmaceuticals Holdings, Inc. (CRBP) Snapshot price: $50.04

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jul 6
Form 3
—
0
—
—
0
No matching records found

ACCELERON PHARMA INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found